$89.06
-0.78-0.87%
Last update: Oct 30, 7:59 AM
Abivax SA (ABVX) Stock Price, Quote, News & History
ABVXNASDAQ
Abivax missed EPS estimates but beat sales in H1; shares dipped. Wedbush and Truist cut price targets to $118 and $151.
You can purchase shares of Abivax (NASDAQ:ABVX) through any online brokerage.
Other companies in Abivax’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Abivax has a consensus price target of $119.86.
The stock price for Abivax (NASDAQ: ABVX) is $87.12 last updated October 30, 2026 at 7:59 AM EDT.
There are no upcoming dividends for Abivax.
Abivax does not have any upcoming earnings scheduled.
There is no upcoming split for Abivax.
Abivax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is...
